IOrganBio Launches From Stealth with $2M Seed Round Led by First Star Ventures

Why It Matters

The financing underscores growing investor confidence in cell‑manufacturing platforms, which could accelerate scalable human cell production and reshape biotech pipelines and drug development.

Deal Summary

iOrganBio announced its launch from stealth and a $2 million seed funding round to transform how human cells are made. The round was led by First Star Ventures with participation from IndieBio, Cape Fear BioCapital, 2ndF, Terasaki Institute, and Alix Ventures.